期刊文献+

真核表达载体pcDNA3.1(-)-IL-3-PE38KDEL的构建及其在CIK细胞中的表达 被引量:1

Construction of eukaryotic expression plasmid pcDNA3.1(-)-IL-3-PE38KDEL and its expression in cytokine-induced killer cells
下载PDF
导出
摘要 目的:构建人白细胞介素-3(interleukin-3,IL-3)和铜绿假单胞菌外毒素(pseudomonas exotoxin,PE)衍生物(PE38KDEL)基因的真核融合表达载体,研究其在细胞因子诱导的杀伤(cytokine induced killer,CIK)细胞中的表达情况。方法:通过PCR获得实验需要的IL-3-PE38KDEL基因片段,构建IL-3-PE38KDEL融合基因的真核表达载体pcDNA3.1(-)-IL-3-PE38KDEL。重组质粒经限制性内切酶及DNA序列测定证实构建成功后,用Liprofectamine2000脂质体转染CIK细胞,然后用RT-PCR及Western blot检测IL-3-PE38KDEL融合蛋白在CIK细胞的表达,用MTS检测细胞上清中融合蛋白的细胞毒作用。结果:酶切分析及DNA序列测定证实,IL-3-PE38KDEL融合基因被成功克隆入真核表达质粒载体pcDNA3.1(-);RT-PCR及Western blot法检测证实重组基因可在CIK细胞中表达,且表达的融合蛋白对HL60细胞有杀伤活性。结论:IL-3-PE38KDEL融合基因可在CIK细胞中表达,为进一步研究融合毒素IL-3-PE38KDEL联合CIK细胞过继免疫治疗对肿瘤细胞的体内外杀伤作用奠定了基础。 Objective:To construct an eukaryotic expressive vector of interleukin-3(IL-3)-PE38KDEL and to study the expressions of this gene in cytokine-induced killer(CIK) cells.Methods:IL-3-PE38KDEL fusion gene was cloned into the eukaryotic expression vector to get the recombinant plasmid pcDNA3.1(-)-IL-3-PE38KDEL by molecular cloning technique.The fusion gene was transfected into CIK cells by Liprofectamine2000 immediately after it was confirmed by restrictive enzyme analysis and sequencing.RTPCR and Western blot were used to confirm expressions of the fusion gene in the CIK cells.Prohibitory effect of fusion protein IL-3PE38KDEL on HL60 cells was assessed by MTS assay.Results:Restrictive endonuclease digestion and sequence analysis revealed that IL-3-PE38KDEL fusion gene was cloned into the eukaryotic expression plasmid vector pcDNA3.1(-).IL-3-PE38KDEL fusion gene could express in the CIK cells and the fusion protein could inhibit HL60 cell growth.Conclusions:IL-3-PE38KDEL fusion gene eukaryotic expression vector is constructed successfully and can be expressed in CIK cells,which provide the basis for the further experiment in vitro and in vivo.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2013年第4期374-377,共4页 Journal of Chongqing Medical University
基金 重庆市自然科学基金资助项目(编号:2009BB5266) 重庆市科技攻关重点资助项目(编号:2009AB5215)
关键词 白细胞介素-3 细胞因子诱导的杀伤细胞 真核表达 interleukin-3 cytokine-induced killer cells eukaryotic expression
  • 相关文献

参考文献12

  • 1Campana D.Should minimal residual disease monitoring in acutelymphoblastic leukemia be standard of care?[J].Curr Hematol Malig Rep, 2012,7(2) : 170-177.
  • 2Leemhuis T, Wells S,Scheffold C,et al.A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma[J].Biol Blood Marrow Tramplant, 2005,11 (3) : 181-187.
  • 3Linn Y C,Hui K M.Cytokine-induced killer cells:NK-like T cells with cytotolytic specificity against leukemia[J].Leuk Lymphoma, 2003, 44(9) : 1457-1462.
  • 4Introna M,Franceschetti M,Ciocca A,et al.Rapid and massive ex- pansion of cord blood-derived cytokine-induced killer cells:an inno- vative proposal for the treatment of leukemia relapse after cord blood transplantation[J].Bone Marrow Transplant, 2006,38 (9) : 621-627.
  • 5江浩,刘开彦,童春容,江滨,陆道培.化疗联合自体细胞因子诱导杀伤细胞治疗急性白血病的临床观察[J].中华内科杂志,2005,44(3):198-201. 被引量:32
  • 6沈燕,陈妤,娄世锋.免疫毒素IL-3-PE38KDEL的表达及活性测定[J].重庆医科大学学报,2008,33(11):1362-1364. 被引量:2
  • 7白凤霞,娄世锋,曾瀚庆,廖乐乐.重组融合蛋白IL-3-PE38KDEL对急性髓性白血病细胞增殖和凋亡的影响[J].中国生物制品学杂志,2011,24(2):179-183. 被引量:2
  • 8Potala S,Sahoo S K,Verma R S.Targeted therapy of cancer using diphtheria toxin-derived immunotoxins[J].Drug Discov Today,2008,13 (17-18) :807-815.
  • 9崔京霞,纪剑飞,倪剑锋,吴文芳.重组铜绿假单胞菌外毒素PE38KDEL的克隆、表达与活性检测[J].中华微生物学和免疫学杂志,2004,24(12):985-990. 被引量:4
  • 10Kim H P,rankel A E,Hogge D E.A diphtheria toxin interleukin- 3 fusion protein synergizes with tyrosine kinase inhibitors in killing leukemic progenitors from BCR/ABL positive acute leukemia [J].Leuk Res,2010,34(8) : 1035-1042.

二级参考文献35

  • 1童春容,陆道培,丘镜莹,何萁.细胞因子诱导的杀伤细胞对慢性髓性白血病细胞的体外净化作用[J].中国实验血液学杂志,1996,4(3):314-318. 被引量:13
  • 2崔京霞,纪剑飞,倪剑锋,吴文芳.重组铜绿假单胞菌外毒素PE38KDEL的克隆、表达与活性检测[J].中华微生物学和免疫学杂志,2004,24(12):985-990. 被引量:4
  • 3吴瑕,张林,屈艺,李明远,蒋中华,李虹.IL-18-PE38融合基因真核表达载体的构建及其在软骨细胞中的表达[J].四川大学学报(医学版),2005,36(4):456-459. 被引量:3
  • 4胡川闽,郭建秀,李鹏,陈安,刘彦仿.抗肝癌单链免疫毒素HAb25(scFv)-PE40的构建及其导向作用的实验研究[J].第三军医大学学报,2005,27(22):2209-2212. 被引量:3
  • 5Monica L,Guzman,Sarah J,et aL Nuclear factor-kappaB is constituti vely activated in primitive human acute myelogenous leukemia cells[J]. Blood, 2001,98 : 2301-2307.
  • 6Janenda K,Batra,David J,et al. Single-Chain immunotoxins directed at the human transferrin receptor containing pseudomonas exotoxin A or diphtheria toxin:Anti-TFR(Fv)-PE40 and DT388-Anti- TFR(Fv)[J]. Molecular And Cellular Biology, 1991,11:2200-2205.
  • 7Chan C H,Blazar B R,Greenfield L,et al. Reactivity of murine cytokine fusion toxin,diphtheria toxin390 -murine interleukin -3 (DT390-mIL-3),with bone marrow progenitor cells[J]. Blood,1996,88: 1445-1456.
  • 8Hope KJ, Jin L, Dick JE. Acute myeliod leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity [J]. Nat Immunol, 2004, 5 (7): 738-743.
  • 9Rowe JM, Andersen J, Cassileth PA, et al. Clinical trials of adults with acute myelogenous leukemia: experience of the Eastern Cooperative Oncology Group//Hiddemann W, Buehner T, Wormann B, et al. Experimental Approaches and Novel Therapies. Acute Leukemia [M]. Berlin: Springer-Vedag,1994: 542.
  • 10Guzman ML, Jordan CT. Considerations for targeting maliglant stem cells in leukemia [J]. Cancer Control, 2004, 11 ( 2): 97-104.

共引文献41

同被引文献20

  • 1Schmidt RE,Murray C,Daley JF. A subset of natural killer cells in peripheral blood displays a mature T cell phenotype[J].Journal of Experimental Medicine,1986,(1):351-356.
  • 2Kim YJ,Lim J,Kang JS. Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells[J].Archives of Pharmacal Research,2010,(11):1789-1795.
  • 3Cui Y,Yang X,Zhu W. Immune response,clinical outcome and safety of dendritic cell vaccine in combination with cytokineinduced killer cell therapy in cancer patients[J].Oncol Lett,2013,(2):537-541.
  • 4Philip R,Epstein LB. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself,gamma interferon and interleukin-1[J].NATURE,1986,(6083):86-89.
  • 5Ha Thi HT,Lim HS,Kim J. Transcriptional and post-translational regulation of Bim is essential for TGF-β and TNF-α-induced apoptosis of gastric cancer cell[J].Biochimica et Biophysica Acta,2013,(6):3584-3592.
  • 6Chu WM. Tumor necrosis factor[J].CANCER LETTERS,2013,(2):222225.
  • 7Liu F,Huang L. Development of non-viral vectors for systemic gene delivery[J].Journal of Controlled Release,2002,(1-3):259-266.doi:10.1016/S0168-3659(01)00494-1.
  • 8Chan CK,Senden T,Jans DA. Supramolecular structure and nuclear targeting efficiency determine the enhancement of transfection by modified polylysines[J].Gene Therapy,2010,(19):1690-1697.
  • 9Prabha S,Zhou WZ,Panyam J. Size-dependency of nanoparticle-mediated gene transfection:studies with fractionated nanoparticles[J].International Journal of Pharmaceutics,2002,(1 2):105-115.doi:10.1016/S0378-5173(02)00315-0.
  • 10Tang MX,Redemann CT,Szoka FC Jr. In vitro gene delivery by degraded polyamidoamine dendrimers[J].Bioconjugate Chemistry,2006,(6):703-714.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部